BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 25190698)

  • 1. Genetic/familial high-risk assessment: breast and ovarian, version 1.2014.
    Daly MB; Pilarski R; Axilbund JE; Buys SS; Crawford B; Friedman S; Garber JE; Horton C; Kaklamani V; Klein C; Kohlmann W; Kurian A; Litton J; Madlensky L; Marcom PK; Merajver SD; Offit K; Pal T; Pasche B; Reiser G; Shannon KM; Swisher E; Voian NC; Weitzel JN; Whelan A; Wiesner GL; Dwyer MA; Kumar R;
    J Natl Compr Canc Netw; 2014 Sep; 12(9):1326-38. PubMed ID: 25190698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary breast and ovarian cancer (HBOC): clinical features and counseling for BRCA1 and BRCA2, Lynch syndrome, Cowden syndrome, and Li-Fraumeni syndrome.
    Shulman LP
    Obstet Gynecol Clin North Am; 2010 Mar; 37(1):109-33, Table of Contents. PubMed ID: 20494261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024.
    Daly MB; Pal T; Maxwell KN; Churpek J; Kohlmann W; AlHilli Z; Arun B; Buys SS; Cheng H; Domchek SM; Friedman S; Giri V; Goggins M; Hagemann A; Hendrix A; Hutton ML; Karlan BY; Kassem N; Khan S; Khoury K; Kurian AW; Laronga C; Mak JS; Mansour J; McDonnell K; Menendez CS; Merajver SD; Norquist BS; Offit K; Rash D; Reiser G; Senter-Jamieson L; Shannon KM; Visvanathan K; Welborn J; Wick MJ; Wood M; Yurgelun MB; Dwyer MA; Darlow SD
    J Natl Compr Canc Netw; 2023 Oct; 21(10):1000-1010. PubMed ID: 37856201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTEN hamartoma tumor syndrome: clinical risk assessment and management protocol.
    Ngeow J; Eng C
    Methods; 2015 May; 77-78():11-9. PubMed ID: 25461771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer risk and clinical implications for germline PTEN mutation carriers.
    Ngeow J; Sesock K; Eng C
    Breast Cancer Res Treat; 2017 Aug; 165(1):1-8. PubMed ID: 26700035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTEN Mutation Identified in Patient Diagnosed with Simultaneous Multiple Cancers.
    Won HS; Chang ED; Na SJ; Whang IY; Lee DS; You SH; Kim YS; Kim JS
    Cancer Res Treat; 2019 Jan; 51(1):402-407. PubMed ID: 29510612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline PTEN mutations in Cowden syndrome-like families.
    Marsh DJ; Dahia PL; Caron S; Kum JB; Frayling IM; Tomlinson IP; Hughes KS; Eeles RA; Hodgson SV; Murday VA; Houlston R; Eng C
    J Med Genet; 1998 Nov; 35(11):881-5. PubMed ID: 9832031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTEN hamartoma tumor syndrome: an overview.
    Hobert JA; Eng C
    Genet Med; 2009 Oct; 11(10):687-94. PubMed ID: 19668082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline mutations in the PTEN gene in Israeli patients with Bannayan-Riley-Ruvalcaba syndrome and women with familial breast cancer.
    Figer A; Kaplan A; Frydman M; Lev D; Paswell J; Papa MZ; Goldman B; Friedman E
    Clin Genet; 2002 Oct; 62(4):298-302. PubMed ID: 12372056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary breast cancer considering Cowden syndrome: a case study.
    Kelly P
    Cancer Nurs; 2003 Oct; 26(5):370-5. PubMed ID: 14710798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic counseling and testing for common hereditary breast cancer syndromes: a paper from the 2007 William Beaumont hospital symposium on molecular pathology.
    Allain DC
    J Mol Diagn; 2008 Sep; 10(5):383-95. PubMed ID: 18687797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cowden syndrome.
    Farooq A; Walker LJ; Bowling J; Audisio RA
    Cancer Treat Rev; 2010 Dec; 36(8):577-83. PubMed ID: 20580873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria.
    Pilarski R; Burt R; Kohlman W; Pho L; Shannon KM; Swisher E
    J Natl Cancer Inst; 2013 Nov; 105(21):1607-16. PubMed ID: 24136893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.
    Daly MB; Pilarski R; Berry M; Buys SS; Farmer M; Friedman S; Garber JE; Kauff ND; Khan S; Klein C; Kohlmann W; Kurian A; Litton JK; Madlensky L; Merajver SD; Offit K; Pal T; Reiser G; Shannon KM; Swisher E; Vinayak S; Voian NC; Weitzel JN; Wick MJ; Wiesner GL; Dwyer M; Darlow S
    J Natl Compr Canc Netw; 2017 Jan; 15(1):9-20. PubMed ID: 28040716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentially pathogenic germline CHEK2 c.319+2T>A among multiple early-onset cancer families.
    Dominguez-Valentin M; Nakken S; Tubeuf H; Vodak D; Ekstrøm PO; Nissen AM; Morak M; Holinski-Feder E; Martins A; Møller P; Hovig E
    Fam Cancer; 2018 Jan; 17(1):141-153. PubMed ID: 28608266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond BRCA1 and BRCA2 wild-type breast and/or ovarian cancer families: germline mutations in TP53 and PTEN.
    Blanco A; Graña B; Fachal L; Santamariña M; Cameselle-Teijeiro J; Ruíz-Ponte C; Carracedo A; Vega A
    Clin Genet; 2010 Feb; 77(2):193-6. PubMed ID: 19930417
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetic/familial high-risk assessment: breast and ovarian.
    Daly MB; Axilbund JE; Buys S; Crawford B; Farrell CD; Friedman S; Garber JE; Goorha S; Gruber SB; Hampel H; Kaklamani V; Kohlmann W; Kurian A; Litton J; Marcom PK; Nussbaum R; Offit K; Pal T; Pasche B; Pilarski R; Reiser G; Shannon KM; Smith JR; Swisher E; Weitzel JN;
    J Natl Compr Canc Netw; 2010 May; 8(5):562-94. PubMed ID: 20495085
    [No Abstract]   [Full Text] [Related]  

  • 18. First report of ovarian dysgerminoma in Cowden syndrome with germline PTEN mutation and PTEN-related 10q loss of tumor heterozygosity.
    Cho MY; Kim HS; Eng C; Kim DS; Kang SJ; Eom M; Yi SY; Bronner MP
    Am J Surg Pathol; 2008 Aug; 32(8):1258-64. PubMed ID: 18594467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel PTEN germline mutation in a family with mild phenotype: difficulties in genetic counseling.
    Busa T; Chabrol B; Perret O; Longy M; Philip N
    Gene; 2013 Jan; 512(2):194-7. PubMed ID: 23124040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Will the real Cowden syndrome please stand up (again)? Expanding mutational and clinical spectra of the PTEN hamartoma tumour syndrome.
    Pilarski R; Eng C
    J Med Genet; 2004 May; 41(5):323-6. PubMed ID: 15121767
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.